Helex
- Biotech or pharma, therapeutic R&D
Helex is extending the frontier of breakthrough genomic medicines to meet the significant unmet needs of patients with chronic kidney diseases, which affect 1 in 7 individuals globally. Looking to meet investors for upcoming seed round
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}